Lincoln R. Potter - Publications

Affiliations: 
1999- Biochemistry, Molecular Biology and Biophysics University of Minnesota, Twin Cities, Minneapolis, MN 
Area:
Biochemistry
Website:
https://cbs.umn.edu/contacts/lincoln-r-potter

39 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Schmidt H, Dickey DM, Dumoulin A, Octave M, Robinson JW, Kühn R, Feil R, Potter LR, Rathjen FG. Regulation of the natriuretic peptide receptor 2 (Npr2) by phosphorylation of juxtamembrane serine and threonine residues is essential for bifurcation of sensory axons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 30249793 DOI: 10.1523/JNEUROSCI.0495-18.2018  0.68
2017 Dickey DM, Otto NM, Potter LR. Skeletal overgrowth-causing mutations mimic an allosterically activated conformation of guanylyl cyclase-B that is inhibited by 2,4,6,-trinitrophenyl ATP. The Journal of Biological Chemistry. PMID 28450398 DOI: 10.1074/jbc.M117.780536  0.68
2017 Otto NM, McDowell WG, Dickey DM, Potter LR. A Glutamate-Substituted Mutant Mimics the Phosphorylated and Active Form of Guanylyl Cyclase-A. Molecular Pharmacology. PMID 28416574 DOI: 10.1124/mol.116.107995  0.68
2016 Dickey DM, Edmund AB, Otto NM, Chaffee TS, Robinson JW, Potter LR. Catalytically Active Guanylyl Cyclase-B Requires ER-mediated Glycosylation and Mutations that Inhibit this Process Cause Dwarfism. The Journal of Biological Chemistry. PMID 26980729 DOI: 10.1074/jbc.M115.704015  1
2015 Shuhaibar LC, Egbert JR, Edmund AB, Uliasz TF, Dickey DM, Yee SP, Potter LR, Jaffe LA. Dephosphorylation of juxtamembrane serines and threonines of the NPR2 guanylyl cyclase is required for rapid resumption of oocyte meiosis in response to luteinizing hormone. Developmental Biology. PMID 26522847 DOI: 10.1016/j.ydbio.2015.10.025  1
2015 Wang SR, Jacobsen CM, Carmichael H, Edmund AB, Robinson JW, Olney RC, Miller TC, Moon JE, Mericq V, Potter LR, Warman ML, Hirschhorn JN, Dauber A. Heterozygous mutations in natriuretic peptide receptor-B (NPR2) gene as a cause of short stature. Human Mutation. 36: 474-81. PMID 25703509 DOI: 10.1002/humu.22773  1
2014 Egbert JR, Shuhaibar LC, Edmund AB, Van Helden DA, Robinson JW, Uliasz TF, Baena V, Geerts A, Wunder F, Potter LR, Jaffe LA. Dephosphorylation and inactivation of NPR2 guanylyl cyclase in granulosa cells contributes to the LH-induced decrease in cGMP that causes resumption of meiosis in rat oocytes. Development (Cambridge, England). 141: 3594-604. PMID 25183874 DOI: 10.1242/dev.112219  1
2014 Buys ES, Potter LR, Pasquale LR, Ksander BR. Regulation of intraocular pressure by soluble and membrane guanylate cyclases and their role in glaucoma. Frontiers in Molecular Neuroscience. 7: 38. PMID 24904270 DOI: 10.3389/fnmol.2014.00038  1
2013 Robinson JW, Dickey DM, Miura K, Michigami T, Ozono K, Potter LR. A human skeletal overgrowth mutation increases maximal velocity and blocks desensitization of guanylyl cyclase-B. Bone. 56: 375-82. PMID 23827346 DOI: 10.1016/j.bone.2013.06.024  1
2012 Robinson JW, Potter LR. Guanylyl cyclases A and B are asymmetric dimers that are allosterically activated by ATP binding to the catalytic domain. Science Signaling. 5: ra65. PMID 22949736 DOI: 10.1126/scisignal.2003253  1
2012 Yoder AR, Robinson JW, Dickey DM, Andersland J, Rose BA, Stone MD, Griffin TJ, Potter LR. A functional screen provides evidence for a conserved, regulatory, juxtamembrane phosphorylation site in guanylyl cyclase a and B. Plos One. 7: e36747. PMID 22590601 DOI: 10.1371/journal.pone.0036747  1
2012 Robinson JW, Zhang M, Shuhaibar LC, Norris RP, Geerts A, Wunder F, Eppig JJ, Potter LR, Jaffe LA. Luteinizing hormone reduces the activity of the NPR2 guanylyl cyclase in mouse ovarian follicles, contributing to the cyclic GMP decrease that promotes resumption of meiosis in oocytes. Developmental Biology. 366: 308-16. PMID 22546688 DOI: 10.1016/j.ydbio.2012.04.019  1
2012 Dickey DM, Dries DL, Margulies KB, Potter LR. Guanylyl cyclase (GC)-A and GC-B activities in ventricles and cardiomyocytes from failed and non-failed human hearts: GC-A is inactive in the failed cardiomyocyte. Journal of Molecular and Cellular Cardiology. 52: 727-32. PMID 22133375 DOI: 10.1016/j.yjmcc.2011.11.007  1
2011 Robinson JW, Potter LR. ATP potentiates competitive inhibition of guanylyl cyclase A and B by the staurosporine analog, Gö6976: reciprocal regulation of ATP and GTP binding. The Journal of Biological Chemistry. 286: 33841-4. PMID 21828054 DOI: 10.1074/jbc.M111.273565  1
2011 Dickey DM, Potter LR. ProBNP(1-108) is resistant to degradation and activates guanylyl cyclase-A with reduced potency. Clinical Chemistry. 57: 1272-8. PMID 21768217 DOI: 10.1373/clinchem.2011.169151  0.68
2011 Dickey DM, Flora DR, Potter LR. Antibody tracking demonstrates cell type-specific and ligand-independent internalization of guanylyl cyclase a and natriuretic peptide receptor C. Molecular Pharmacology. 80: 155-62. PMID 21498657 DOI: 10.1124/mol.110.070573  1
2011 Dickey DM, Potter LR. Dendroaspis natriuretic peptide and the designer natriuretic peptide, CD-NP, are resistant to proteolytic inactivation. Journal of Molecular and Cellular Cardiology. 51: 67-71. PMID 21459096 DOI: 10.1016/j.yjmcc.2011.03.013  0.68
2011 Robinson JW, Lou X, Potter LR. The indolocarbazole, Gö6976, inhibits guanylyl cyclase-A and -B. British Journal of Pharmacology. 164: 499-506. PMID 21366551 DOI: 10.1111/j.1476-5381.2011.01291.x  1
2011 Ralat LA, Guo Q, Ren M, Funke T, Dickey DM, Potter LR, Tang WJ. Insulin-degrading enzyme modulates the natriuretic peptide-mediated signaling response. The Journal of Biological Chemistry. 286: 4670-9. PMID 21098034 DOI: 10.1074/jbc.M110.173252  1
2010 Yoder AR, Stone MD, Griffin TJ, Potter LR. Mass spectrometric identification of phosphorylation sites in guanylyl cyclase A and B. Biochemistry. 49: 10137-45. PMID 20977274 DOI: 10.1021/bi101700e  1
2010 Dickey DM, Potter LR. Human B-type natriuretic peptide is not degraded by meprin A. Biochemical Pharmacology. 80: 1007-11. PMID 20599787 DOI: 10.1016/j.bcp.2010.06.015  0.68
2010 Dickey DM, Barbieri KA, McGuirk CM, Potter LR. Arg13 of B-type natriuretic Peptide reciprocally modulates binding to guanylyl cyclase but not clearance receptors. Molecular Pharmacology. 78: 431-5. PMID 20530652 DOI: 10.1124/mol.110.066084  1
2010 Flora DR, Potter LR. Prolonged atrial natriuretic peptide exposure stimulates guanylyl cyclase-a degradation. Endocrinology. 151: 2769-76. PMID 20382697 DOI: 10.1210/en.2009-1239  1
2009 Pan S, Chen HH, Dickey DM, Boerrigter G, Lee C, Kleppe LS, Hall JL, Lerman A, Redfield MM, Potter LR, Burnett JC, Simari RD. Biodesign of a renal-protective peptide based on alternative splicing of B-type natriuretic peptide. Proceedings of the National Academy of Sciences of the United States of America. 106: 11282-7. PMID 19541613 DOI: 10.1073/pnas.0811851106  1
2009 Dickey DM, Yoder AR, Potter LR. A familial mutation renders atrial natriuretic Peptide resistant to proteolytic degradation. The Journal of Biological Chemistry. 284: 19196-202. PMID 19458086 DOI: 10.1074/jbc.M109.010777  0.68
2009 Potter LR, Yoder AR, Flora DR, Antos LK, Dickey DM. Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications. Handbook of Experimental Pharmacology. 341-66. PMID 19089336 DOI: 10.1007/978-3-540-68964-5_15  1
2008 Dickey DM, Burnett JC, Potter LR. Novel bifunctional natriuretic peptides as potential therapeutics. The Journal of Biological Chemistry. 283: 35003-9. PMID 18940797 DOI: 10.1074/jbc.M804538200  1
2008 Yoder AR, Kruse AC, Earhart CA, Ohlendorf DH, Potter LR. Reduced ability of C-type natriuretic peptide (CNP) to activate natriuretic peptide receptor B (NPR-B) causes dwarfism in lbab -/- mice. Peptides. 29: 1575-81. PMID 18554750 DOI: 10.1016/j.peptides.2008.04.020  0.68
2007 Antos LK, Potter LR. Adenine nucleotides decrease the apparent Km of endogenous natriuretic peptide receptors for GTP. American Journal of Physiology. Endocrinology and Metabolism. 293: E1756-63. PMID 17848634 DOI: 10.1152/ajpendo.00321.2007  0.84
2007 Dickey DM, Flora DR, Bryan PM, Xu X, Chen Y, Potter LR. Differential regulation of membrane guanylyl cyclases in congestive heart failure: natriuretic peptide receptor (NPR)-B, Not NPR-A, is the predominant natriuretic peptide receptor in the failing heart. Endocrinology. 148: 3518-22. PMID 17412809 DOI: 10.1210/en.2007-0081  1
2007 Bryan PM, Xu X, Dickey DM, Chen Y, Potter LR. Renal hyporesponsiveness to atrial natriuretic peptide in congestive heart failure results from reduced atrial natriuretic peptide receptor concentrations. American Journal of Physiology. Renal Physiology. 292: F1636-44. PMID 17264312 DOI: 10.1152/ajprenal.00418.2006  1
2006 Bryan PM, Smirnov D, Smolenski A, Feil S, Feil R, Hofmann F, Lohmann S, Potter LR. A sensitive method for determining the phosphorylation status of natriuretic peptide receptors: cGK-Ialpha does not regulate NPR-A. Biochemistry. 45: 1295-303. PMID 16430226 DOI: 10.1021/bi051253d  1
2006 Potter LR, Abbey-Hosch S, Dickey DM. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocrine Reviews. 27: 47-72. PMID 16291870 DOI: 10.1210/er.2005-0014  0.68
2005 Abbey-Hosch SE, Smirnov D, Potter LR. Differential regulation of NPR-B/GC-B by protein kinase c and calcium. Biochemical Pharmacology. 70: 686-94. PMID 16005434 DOI: 10.1016/j.bcp.2005.04.034  0.72
2005 Antos LK, Abbey-Hosch SE, Flora DR, Potter LR. ATP-independent activation of natriuretic peptide receptors. The Journal of Biological Chemistry. 280: 26928-32. PMID 15911610 DOI: 10.1074/jbc.M505648200  1
2005 Fan D, Bryan PM, Antos LK, Potthast RJ, Potter LR. Down-regulation does not mediate natriuretic peptide-dependent desensitization of natriuretic peptide receptor (NPR)-A or NPR-B: guanylyl cyclase-linked natriuretic peptide receptors do not internalize. Molecular Pharmacology. 67: 174-83. PMID 15459247 DOI: 10.1124/mol.104.002436  1
2004 Potthast R, Abbey-Hosch SE, Antos LK, Marchant JS, Kuhn M, Potter LR. Calcium-dependent dephosphorylation mediates the hyperosmotic and lysophosphatidic acid-dependent inhibition of natriuretic peptide receptor-B/guanylyl cyclase-B. The Journal of Biological Chemistry. 279: 48513-9. PMID 15371450 DOI: 10.1074/jbc.M408247200  0.84
2004 Abbey-Hosch SE, Cody AN, Potter LR. Sphingosine-1-phosphate inhibits C-type natriuretic peptide activation of guanylyl cyclase B (GC-B/NPR-B). Hypertension. 43: 1103-9. PMID 15037564 DOI: 10.1161/01.HYP.0000124668.80811.d3  0.72
2002 Bryan PM, Potter LR. The atrial natriuretic peptide receptor (NPR-A/GC-A) is dephosphorylated by distinct microcystin-sensitive and magnesium-dependent protein phosphatases. The Journal of Biological Chemistry. 277: 16041-7. PMID 11821394 DOI: 10.1074/jbc.M110626200  1
Show low-probability matches.